Skip to main content
Premium Trial:

Request an Annual Quote

Rare Heart Inflammation Warning

The US Food and Drug Administration is adding a warning that notes a link between a rare inflammatory heart condition among teens and young adults and the Pfizer-BioNTech and Moderna SARS-CoV-2 vaccines, Reuters reports.

It says that an advisory panel to the Centers for Disease Control and Prevention found there was a "likely association" between the mRNA-based vaccines and the condition but that the benefits of vaccination still outweigh the risks. According to CNBC, there have been about 1,200 cases of myocarditis or pericarditis among people 30 years old or younger who received the Pfizer-BioNTech or Moderna SARS-CoV-2 vaccines, noting that 300 million doses have been administered.

"This is still a rare event," Tom Shimabukuro, deputy director of the CDC's Immunization Safety Office, said during the meeting of the CDC's Advisory Committee on Immunization Practices, according to CNBC.

The CDC notes that individuals who develop the inflammation typically recover, Reuters says. It further reports that Pfizer says it has not observed a higher-than-expected rate of inflammation and that Moderna says it is aware of the reports and is working with regulators and public health officials.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.